This program has 10 episodes which will help you understand the journey from identifying early signs and symptoms to the timely diagnosis and effective management of a child with narcolepsy. The program also focuses on the psychosocial impact of the diagnosis.
Pediatric Narcolepsy: How to Address Its Burden of Illness Through Prompt Recognition, Diagnosis, and Management
10
episodes
1.00 program credits1h 05m
Details
Presenters
Related
Comments
Disclosure of Relevant Financial Relationships
In accordance with the ACCME Standards for Integrity and Independence, Global Learning Collaborative (GLC) requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any ineligible company. GLC mitigates all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational programs.
Kiran Maski, MD, MPH
Associate Professor of Neurology
Harvard Medical School
Boston, MADr. Maski has reported the following relevant financial relationships or relationships with ineligible companies of any amount during the past 24 months:
Research: Jase Pharmaceuticals, Harmony Bioscience
Receives royalties: Up to Date
Consulting Fees: Takeda, Avadel, Alkermes, Zevva, Eisai, Karuma, PaladinFunke Afolabi-Brown, MD
CEO, Restful Sleep MD
University of Pennsylvania
Spring House, PADr. Afolabi-Brown has reported the following relevant financial relationships or relationships with ineligible companies of any amount during the past 24 months:
Other: Avadel Speaker BureauAnne Marie Morse, DO
Director, Division of Child Neurology
Director, Division of Pediatric Sleep Medicine
Geisinger Medical Center
Danville, PADr. Morse has reported the following relevant financial relationships or relationships with ineligible companies of any amount during the past 24 months:
Research: Jazz Pharmaceuticals, Avadel, UCB Pharmaceuticals
Consulting Fees: Jazz Pharma, Harmony Biosciences, Zevra, Takeda, Avadel, Alkermes
Other: CEO and Founder, DAMM Good Sleep, LLCReviewers/Content Planners/Authors:
- Brian P. McDonough, MD, FAAFP, has nothing to disclose.
- Tim Person has nothing to disclose.
- Prerna Poojary has nothing to disclose.
Learning Objectives
After participating in this educational activity, participants should be better able to:
- Delineate key differences among the clinical manifestations of narcolepsy symptoms in children versus adults
- Define the physical, psychological, and social comorbidities associated with pediatric narcolepsy
- Define the benefits and risks of current and evolving pharmacologic therapies that can optimize treatment outcomes for pediatric narcolepsy
Target Audience
This activity has been designed to meet the educational needs of Sleep Medicine Specialists, Pediatricians, Neurologists, and Pulmonologists as well as all other physicians, physician assistants, nurse practitioners, nurses, pharmacists, and healthcare providers involved in managing patients with pediatric narcolepsy.
Accreditation and Credit Designation Statements
In support of improving patient care, Global Learning Collaborative (GLC) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.Global Learning Collaborative (GLC) designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Global Learning Collaborative (GLC) designates this activity for 1.0 nursing contact hours. Nurses should claim only the credit commensurate with the extent of their participation in the activity.
Global Learning Collaborative (GLC) has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credits. Approval is valid until 7/22/2025. PAs should claim only the credit commensurate with the extent of their participation in the activity.
Global Learning Collaborative (GLC) designates this activity for 1 contact hours/0.10 CEUs of pharmacy contact hours.1
The Universal Activity Number for this program is JA0006235-0000-24-087-H01-P. This learning activity is knowledge-based. Your CE credits will be electronically submitted to the NABP upon successful completion of the activity. Pharmacists with questions can contact NABP customer service (custserv@nabp.net).Provider(s)/Educational Partner(s)
Prova Education designs and executes continuing education founded on evidence-based medicine, clinical need, gap analysis, learner feedback, and more. Our mission is to serve as an inventive and relevant resource for clinical content and educational interventions across a broad spectrum of specialties.Prova Education's methodology demonstrates a commitment to continuing medical education and the innovative assessment of its effects. Our goal is clear—to develop and deliver the best education in the most impactful manner and to verify its results with progressive outcomes research.
It’s about time! Today’s on-the-go learners have minutes to spend on education instead of hours. Total CME, LLC, is an award-winning, global healthcare education company that strategically pioneers methodology, initiatives, and platforms to meet these time-limited needs. Unlike other medical education companies, Total CME employs a microlearning approach and platform to create outcome-based curricula that motivates HCPs to engage in self-directed point-of-care learning that impacts change in real time. Even while reaching the largest global distribution, we provide the most personalized, seamless learner experience. We’re meeting our busy learners where they are so they can focus on what they want when they need it, ultimately leading to behavior changes that impact clinical practice and empower patients in their own care.
Commercial Support
This activity is supported by an independent educational grant from Avadel CNS Pharmaceuticals, LLC and Harmony Biosciences, LLC.
Disclaimer
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of GLC, Prova Education, and Total CME, LLC. This presentation is not intended to define an exclusive course of patient management; the participant should use his/her clinical judgment, knowledge, experience, and diagnostic skills in applying or adopting for professional use any of the information provided herein. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients’ conditions and contraindications or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. Links to other sites may be provided as additional sources of information. Once you elect to access a site outside of Prova Education and Total CME, LLC, you are subject to the terms and conditions of use, including copyright and licensing restriction, of that site.
Reproduction Prohibited
Reproduction of this material is not permitted without written permission from the copyright owner.System Requirements
- Supported Browsers (2 most recent versions):
- Google Chrome for Windows, Mac OS, iOS, and Android
- Apple Safari for Mac OS and iOS
- Mozilla Firefox for Windows, Mac OS, iOS, and Android
- Microsoft Edge for Windows
- Recommended Internet Speed: 5Mbps+
Publication Dates
Release Date:
Expiration Date:
